Effects of Exercise on the Renin-angiotensin System
The Effects of Exercise and Training Status on the Counter-regulatory Axis of the Renin-angiotensin-system.
1 other identifier
interventional
24
1 country
1
Brief Summary
Angiotensin converting enzyme-2 (ACE2) is part of the renin-angiotensin system (RAS), which is involved in maintaining blood flow and electrolyte balance. It has been shown in obese and hypertensive individuals that levels of another molecule Angiotensin converting enzyme (ACE) are much higher, leading to inflammation, fibrosis, vasoconstriction and high blood pressure. ACE2 has a protective effect from ACE, leading to anti-inflammatory, anti-fibrotic and vasodilating effects. In animal models, it has been shown that aerobic exercise can increase levels of ACE2, while decreasing levels of ACE and offers protection to the cardiovascular system by keeping these two molecules balanced. Although the effects of exercise on the classical arm of the RAS have been studied significantly, ACE2 is a relatively new discovery and has not been studied as extensively in humans. The purpose of this research is to determine the effects of exercise training status on the RAS, specifically on ACE2 and its products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2021
CompletedFirst Posted
Study publicly available on registry
November 10, 2021
CompletedStudy Start
First participant enrolled
July 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedJuly 15, 2022
July 1, 2022
6 months
October 3, 2021
July 12, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in the mean response to an acute bout of physical activity in the components of the renin-angiotensin system
Measurements of Angiotensin(1-10) and Angiotensin(1-9) will be analyzed using ELISA kits.
measurements will be taken before, immediately post and 30 minutes post exercise.
Secondary Outcomes (1)
Changes in the baseline measurements of the renin-angiotensin system between physically active and sedentary males.
Measurements will be made prior to commencement of exercise protocols.
Study Arms (2)
Sedentary Group
ACTIVE COMPARATORIndividuals who are physically active for less than 75 minutes of moderate to vigorous physical activity a week will be placed in the sedentary group.
Active Group
ACTIVE COMPARATORIndividuals who are physically active for greater than 150 minutes of moderate to vigorous physical activity will be placed in the active group.
Interventions
The participant will be equipped with a vo2 mask or mouthpiece. They will get on the bike and begin with a 5 minute warmup ranging from 30-100 watts. After the warm up there will be a 15-30 watt increase every minute in the cadence that the participant is required to maintain. Once the participant has decided to stop pedalling, the participants mask will be removed to ensure they are feeling well. They will allowed to continue pedaling at their own pace for a cool down for up to two minutes.
Eligibility Criteria
You may qualify if:
- between the ages of 18-39
- ability to exercise to exhaustion
- ability to give informed consent
You may not qualify if:
- chronic consumption of recreational drugs, tobacco or alcohol
- on any prescription medication or anti-inflammatory medications
- diagnosed with any chronic conditions
- current diagnosis with COVID-19
- BMI \>30
- Engage in 75-150 minutes of moderate to vigorous physical activity a week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Exercise Nutrition Laboratory, Western University
London, Ontario, N6A3K7, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2021
First Posted
November 10, 2021
Study Start
July 8, 2022
Primary Completion
December 31, 2022
Study Completion
April 30, 2023
Last Updated
July 15, 2022
Record last verified: 2022-07